Antiviral antibiotic BU-3889V
    1.
    发明授权
    Antiviral antibiotic BU-3889V 失效
    抗病毒抗生素BU-3889V

    公开(公告)号:US5286649A

    公开(公告)日:1994-02-15

    申请号:US819543

    申请日:1992-01-10

    CPC分类号: C12P1/06 Y10S435/822

    摘要: Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A.sub.1, A.sub.2, A.sub.3, D.sub.1, D.sub.2 and D.sub.3, by fermentation of a BU-3889V producing strain of the new microorganism Amycolatopsis orientalis ATCC-53884 is disclosed. Complex BU-3889V is recovered and the components separated by the use of ion exchange chromatography techniques. The bioactive components are characterized by their physico-chemical characterizing properties. The products have been found to be effective to inhibit viruses including herpes simplex virus, human immunodeficiency virus (HIV) and influenza virus.

    摘要翻译: 公开了通过新型微生物Amycolatopsis orientalis ATCC-53884的BU-3889V生产菌株的发酵生产抗病毒抗生素复合物BU-3889V及其生物活性成分A1,A2,A3,D1,D2和D3。 通过使用离子交换色谱技术分离复合物BU-3889V并将组分分离。 生物活性成分的特征在于其物理化学性质。 已经发现这些产品有效地抑制包括单纯疱疹病毒,人类免疫缺陷病毒(HIV)和流感病毒在内的病毒。

    Antiviral antibiotic BU-3889V
    2.
    发明授权
    Antiviral antibiotic BU-3889V 失效
    抗病毒抗生素BU-3889V

    公开(公告)号:US5098708A

    公开(公告)日:1992-03-24

    申请号:US546463

    申请日:1990-07-06

    IPC分类号: C12P1/06

    摘要: Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A.sub.1, A.sub.2, A.sub.3, D.sub.1, D.sub.2 and D.sub.3, by fermentation of a BU-3889V producing strain of the new microorganism Amycolatopsis orientalis ATCC-53884 is disclosed. Complex BU-3889V is recovered and the components separated by the use of ion exchange chromatography techniques. The bioactive components are characterized by their physico-chemical characterizing properties. The products have been found to be effective to inhibit viruses including herpes simplex virus, human immunodeficiency virus (HIV) and influenza virus.

    摘要翻译: 公开了通过新型微生物Amycolatopsis orientalis ATCC-53884的BU-3889V生产菌株的发酵生产抗病毒抗生素复合物BU-3889V及其生物活性成分A1,A2,A3,D1,D2和D3。 通过使用离子交换色谱技术分离复合物BU-3889V并将组分分离。 生物活性成分的特征在于其物理化学性质。 已经发现这些产品有效地抑制包括单纯疱疹病毒,人类免疫缺陷病毒(HIV)和流感病毒在内的病毒。

    Process for preparing antiviral antibiotic BU-3889V
    3.
    发明授权
    Process for preparing antiviral antibiotic BU-3889V 失效
    制备抗病毒抗生素BU-3889V的方法

    公开(公告)号:US5124150A

    公开(公告)日:1992-06-23

    申请号:US624029

    申请日:1991-03-11

    IPC分类号: C12P1/06

    CPC分类号: C12P1/06 Y10S435/822

    摘要: Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A.sub.1, A.sub.2, A.sub.3, D.sub.1, D.sub.2 and D.sub.3, by fermentation of a BU-3889V producing strain of the new microorganism Amycolatopsis orientalis ATCC-53884 is disclosed. Complex BU-3889V is recovered and the components separated by the use of ion exchange chromatography techniques. The bioactive components are characterized by their physico-chemical characterizing properties. The products have been found to be effective to inhibit viruses including herpes simplex virus, human immunodeficiency virus (HIV) and influenza virus.

    摘要翻译: 公开了通过新型微生物Amycolatopsis orientalis ATCC-53884的BU-3889V生产菌株的发酵生产抗病毒抗生素复合物BU-3889V及其生物活性成分A1,A2,A3,D1,D2和D3。 通过使用离子交换色谱技术分离复合物BU-3889V并将组分分离。 生物活性成分的特征在于其物理化学性质。 已经发现这些产品有效地抑制包括单纯疱疹病毒,人类免疫缺陷病毒(HIV)和流感病毒在内的病毒。

    Antiviral antibiotic complex
    8.
    发明授权
    Antiviral antibiotic complex 失效
    抗病毒抗生素复合物

    公开(公告)号:US4803224A

    公开(公告)日:1989-02-07

    申请号:US857878

    申请日:1986-05-01

    CPC分类号: C12P13/02 C08G69/26

    摘要: There is disclosed an antibiotic complex designated as BU-2231 V which is produced by fermentation of a BU-2231-producing strain of Streptoalloteichus hindustanus, ATCC 31158. Complex BU-2231 V is recovered and purified from the fermentation broth by use of ion exchange chromatography techniques. Structural analysis shows that the complex is a mixture of components which are .gamma.-homopolymers of D-.alpha.,.gamma.-diaminobutyric acid having an average molecular weight of from about 5,100 to about 5,200. BU-2231 V has been found to be effective to inhibit growth of various Gram-positive and Gram-negative bacteria and of the herpes simplex virus.

    摘要翻译: 公开了一种称为BU-​​2231V的抗生素复合物,其通过发酵产生的BU-2231产生的Streptoalloteichus hindustanus,ATCC 31158的菌株产生。通过使用离子交换从发酵液中回收并纯化复合物BU-2231V 色谱技术。 结构分析表明,该复合物是组分的混合物,其是平均分子量为约5100至约5200的D-α,γ-二氨基丁酸的γ-均聚物。 已经发现BU-2231V有效抑制各种革兰氏阳性和革兰氏阴性菌和单纯疱疹病毒的生长。

    Antiviral antibiotic BU-4344V
    10.
    发明授权
    Antiviral antibiotic BU-4344V 失效
    抗病毒抗生素BU-4344V

    公开(公告)号:US5256548A

    公开(公告)日:1993-10-26

    申请号:US874775

    申请日:1992-04-27

    CPC分类号: C12R1/03 C07K7/06 Y10S435/825

    摘要: There is provided a new antiviral antibiotic designated herein as BU-4344V which is produced by fermentation of a BU-4344V-producing strain of a new microorganism, Actinomadura parvosata subsp. kistnae ATCC No. 55076. Antibiotic BU-4344V is recovered and purified from the fermentation broth by use of extraction, chromatography, and crystallization techniques. BU-4344V has been found to have some antibacterial activity and inhibits the growth of viruses, including influenza virus type A.

    摘要翻译: 提供了本文命名为BU-4344V的新的抗病毒抗生素,其通过发酵新生微生物(Actinomadura parvosata subsp。)的BU-4344V生产菌株而产生。 kistnae ATCC No.50576.通过使用提取,色谱和结晶技术从发酵液中回收和纯化抗生素BU-4344V。 已经发现BU-4344V具有一些抗菌活性并抑制病毒的生长,包括A型流感病毒。